Back to Screener

American Shared Hospital Services (AMS)

Price$1.50

Favorite Metrics

Price vs S&P 500 (26W)-51.12%
Price vs S&P 500 (4W)-41.96%
Market Capitalization$8.98M
P/E Ratio (Annual)4.08x

All Metrics

P/CF (Annual)2.90x
Book Value / Share (Quarterly)$3.66
P/TBV (Annual)0.58x
Revenue Growth (3Y)12.45%
Cash Flow / Share (Quarterly)$-0.69
Price vs S&P 500 (YTD)-41.51%
Gross Margin (TTM)18.03%
Net Profit Margin (TTM)-5.53%
EPS (TTM)$-0.23
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$-0.23
Revenue Growth (5Y)9.50%
EPS (Annual)$-0.23
ROI (Annual)-3.76%
Gross Margin (Annual)18.03%
Net Profit Margin (5Y Avg)2.57%
Cash / Share (Quarterly)$0.53
Revenue Growth QoQ (YoY)-14.79%
EPS Growth (5Y)23.99%
P/E Normalized (Annual)4.08x
ROA (Last FY)-2.80%
Revenue Growth TTM (YoY)-0.91%
EBITD / Share (TTM)$0.56
ROE (5Y Avg)2.41%
Operating Margin (TTM)-12.78%
Cash Flow / Share (Annual)$-0.69
P/B Ratio0.37x
P/B Ratio (Quarterly)0.57x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.81x
Net Interest Coverage (TTM)0.99x
ROA (TTM)-2.57%
EV / EBITDA (TTM)6.17x
EPS Incl Extra (Annual)$-0.23
Current Ratio (Annual)0.76x
Quick Ratio (Quarterly)0.72x
3-Month Avg Trading Volume0.01M
52-Week Price Return-52.40%
EV / Free Cash Flow (Annual)3.36x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.64
P/S Ratio (Annual)0.32x
Asset Turnover (Annual)0.51x
52-Week High$3.11
Operating Margin (5Y Avg)1.93%
EPS Excl Extra (Annual)$-0.23
CapEx CAGR (5Y)75.39%
Tangible BV CAGR (5Y)4.54%
26-Week Price Return-47.13%
Quick Ratio (Annual)0.72x
13-Week Price Return-40.28%
Total Debt / Equity (Annual)0.72x
Current Ratio (Quarterly)0.76x
Enterprise Value$22.811
Revenue / Share Growth (5Y)8.02%
Asset Turnover (TTM)0.46x
Book Value / Share Growth (5Y)1.89%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)350.53x
Pretax Margin (Annual)-11.47%
Cash / Share (Annual)$0.53
3-Month Return Std Dev48.02%
Gross Margin (5Y Avg)34.97%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)-3.35%
EBITDA Interim CAGR (5Y)-4.19%
ROE (Last FY)-6.46%
Net Interest Coverage (Annual)5.94x
EPS Basic Excl Extra (Annual)$-0.23
P/FCF (TTM)7.01x
Receivables Turnover (TTM)2.54x
Total Debt / Equity (Quarterly)0.72x
EPS Incl Extra (TTM)$-0.23
Receivables Turnover (Annual)2.54x
ROI (TTM)-3.43%
P/S Ratio (TTM)0.32x
Pretax Margin (5Y Avg)2.86%
Revenue / Share (Annual)$4.24
Tangible BV / Share (Annual)$3.64
Forward P/E50.00x
Price vs S&P 500 (52W)-82.23%
Year-to-Date Return-38.86%
5-Day Price Return-3.01%
EPS Normalized (Annual)$-0.23
ROA (5Y Avg)1.11%
Net Profit Margin (Annual)-5.53%
Month-to-Date Return-11.03%
Cash Flow / Share (TTM)$0.85
EBITD / Share (Annual)$0.56
EPS Growth (3Y)118.18%
Operating Margin (Annual)-12.78%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)2.90x
ROI (5Y Avg)1.40%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.23
P/TBV (Quarterly)0.58x
P/B Ratio (Annual)0.57x
Inventory Turnover (TTM)779.20x
Pretax Margin (TTM)-11.47%
Book Value / Share (Annual)$3.66
Price vs S&P 500 (13W)-40.97%
Net Margin Growth (5Y)19.23%
Beta0.29x
P/FCF (Annual)1.31x
Revenue / Share (TTM)$4.20
ROE (TTM)-6.36%
52-Week Low$1.25

Analyst Recommendations

Sep 2021
Oct 2021
Nov 2021
Dec 2021
4.00
4.00
4.00
4.00

Industry Peers — Health Services(20)

SymbolP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
AMSAmerican Shared Hospital Services
4.08x-0.91%-12.78%-6.36%$1.50
NTRANatera, Inc. Common Stock
35.90%-13.44%-15.28%$196.11
LHLabcorp Holdings Inc.
25.08x7.25%9.92%10.28%$266.36
DGXQuest Diagnostics Inc.
21.24x11.78%14.10%13.88%$191.46
EXASExact Sciences Corp
17.69%-6.35%-8.51%$104.91
GHGuardant Health, Inc. Common Stock
32.88%-45.02%-246.60%$85.70
RDNTRadNet, Inc. Common Stock
1779.27x11.51%3.04%-1.88%$60.09
VCYTVeracyte, Inc.
40.04x16.01%11.17%5.33%$33.03
GRALGRAIL, Inc. Common Stock
17.18%-381.98%-17.11%$49.47
CDNACareDx, Inc.
18.34x13.79%-8.10%-6.47%$22.42
FTREFortrea Holdings Inc. Common Stock
1.00%-32.04%-152.17%$10.09

About

American Shared Hospital Services supplies specialized radiation therapy equipment, including Gamma Knife stereotactic radiosurgery systems and advanced radiation therapy devices, to hospitals and standalone medical facilities. The company operates three main business segments: Gamma Knife systems, advanced radiation therapy equipment and services, and proton beam radiation therapy operations. Revenue is primarily generated from the domestic U.S. market.